The reproducibility of nuclear morphometric measurements in invasive breast carcinoma

Analytical Cellular Pathology

Volumn 15, Issue 1, 1997, Pages 47-59

  Kronqvist, Pauliina ^a   Kuopio, Teijo ^a   Collan, Yrjö ^a   Horvath, Csaba ^b   Tamm, Ülle ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

Breast cancer; Morphometry; Nuclear pleomorphism; Nuclear profile area; Reproducibility; Sources of variation

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CELL NUCLEUS; COMPUTER ANALYSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MORPHOMETRICS; OBSERVER VARIATION; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 0030881009     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/402125     Document Type: Article

References (38)

1. J.P. Baak, P.J. van Diest, A.T. Ariens, M.W. van Beek, S.M Bellot, J. Fijnheer, L.H. van Gorp, W.S. Kwee, J. Los and H.C. Peterse, Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessment in the Netherlands, Path. Res. Pract. 185 (1989), 664-670.
2. B. Baldetorp, P.O. Bendahl, M. Fernö, K. Alanen, U. Delle, U. Falkmer, B. Hansson-Aggesjö, T. Höckenström, A. Lindgren, L. Mossberg, S. Nordling, H. Sigurdsson, O. Stål and T. Visakorpi, Reproducibility in DNA flow cytometric analysis of breast cancer: Comparison of 12 laboratories' results for 67 sample homogenates, Cytometry 22 (1995), 115-127.
3. J.D. Barry and F.E. Sharkey, Observers reproducibility during computer-assisted planimetric measurements of nuclear features, Hum. Pathol. 16 (1985), 225-227.
4. E. Bergers, P.J. van Diest and J.P. Baak, Reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material, Anal. Cell. Pathol. 8 (1995), 1-13 (abstr.).
5. S. Biesterfeld, I. Noll, E. Noll, D. Wohltmann and A. Böcking, Mitotic frequency as a prognostic factor in breast cancer, Hum. Pathol. 26 (1995), 47-52.
6. H.J.G. Bloom and W.W. Richardson, Histological grading and prognosis in breast cancer, Br. J. Cancer 11 (1957), 359-377.
7. Breast cancer Prognostic factors - the search goes on [News], Journal of the National Cancer Institute 86(7) (1994), 480-482.
8. K.W. Chan, K.Y. Chiu, K.H. Fu and J.M.L. Ling, Observer variability in microcomputer-assisted morphometric study of nuclear parameters, Pathology 19 (1987), 407-409.
9. Y. Collan, R. Montironi, G.M. Mariuzzi, T. Torkkeli, F. Marinelli, E. Pesonen, G. Collina, V.-M. Kosma, E. Jantunen and O. Kosunen, Observer variation in interactive computerized morphometry, Appl. Pathol. 4 (1986), 9-14.
10. Y. Collan, T. Torkkeli, V.-M. Kosma, E. Pesonen, O. Kosunen, E. Jantunen, G.M. Mariuzzi, R. Montironi, F. Marinelli and G. Collina, Sampling in diagnostic morphometry: the influence of variation sources, Path. Res. Pract. 182 (1987), 401-406.
11. Y. Collan, General principles of grading lesions in diagnostic histopathology, Path. Res. Pract. 185 (1989), 539-543.
12. Y. Collan, T. Kuopio, J.P.A. Baak, R. Becker, W.V. Bogomoletz, M. Deverell, P. van Diest, C. van Galen, K. Gilchrist, A. Jared, V.-M. Kosma, H. Kujari, P. Luzi, G.M. Mariuzzi, E. Matze, R. Montironi, M. Scarpelli, D. Sierra, S. Sisti, S. Toikkanen, P. Tosi, W.F. Whimster and E. Wisse, Standardized mitotic counts in breast cancer. Evaluation of the method, Path. Res. Pract. 192 (1996), 931-941.
13. Y. Collan and E. Pesonen, Principles of morphometric grading, Gegenbaurs Morphol. Jahrbuch 135 (1989), 13-17.
14. Y. Collan, P. Klemi, O. Kallioniemi, H. Joensuu, S. Nordling and M. Eskelinen, Significance of variation in DNA flow cytometric analyses from paraffin-embedded breast cancers. Evaluation of the grading efficiency of ploidy determination, DNA index, and S-phase fraction, Path. Res. Pract. 188 (1992), 581-586.
15. L.W. Dalton, D.L. Page and W.D. Dupont, Histologic grading of breast carcinoma. A reproducibility study, Cancer 73 (1994), 2765-2770.
16. B.W. Davis, R.D. Gelber, A. Goldhisch, W.H. Hartmann, G.W. Locher, R. Reed, R. Golouh, J. Säve-Söderbergh, L. Holloway, I. Russel and C.M. Rudenstam, Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis, Cancer 58 (1986), 2662-2672.
17. G.S. Delides, G. Garas, G. Georgouli, D. Jiortziotis, J. Lecca, T. Liva and J. Elemenoglou, Intralaboratory variations in the grading of breast carcinoma, Arch. Pathol. Lab. Med. 106 (1982), 126-128.
18. P.J. van Diest, A.W.M. Smeulders, F.B.J.M. Thunnisen and J.P.A. Baak, Cytomorphometry. A methodological study of preparation techniques, selection methods and sample sizes, Anal. Quant. Cytol. Histol. 11 (1989), 225-231.
19. P.J.A. van Diest, J.P. Baak, P. Matze-Cok, E.C.M. Wisse-Brekelmans, C.M. van Galen, P.H.J. Kurver, S.M. Bellot, J. Fijnheer, L.H.M. van Gorp, W.S. Kwee, J. Los, J.L. Peterse, H.M. Ruitenberg, R.F.M. Schapers, M.E.I. Schipper, J.G. Somsen, A.W.P.M. Willig and A.Th. Ariens, Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project (MMMCP), Hum. Pathol. 23 (1992), 603-607.
20. L.G. Dressier, L. Seamer, M. A. Owens, G.M. Clark and W.L. McGuire, Evaluation of a modelling system for S-phase estimation in breast cancer by flow cytometry, Cancer Res. 47 (1987), 5294-5302.
21. M. Fernö, B. Baldetorp, S.-B. Ewers, I. Idvall, H. Olsson, H. Sigurdsson and D. Killander, One or multiple samplings for flow cytometric DNA-analyses in breast cancer - prognostic implications?, Cytometry 13 (1992), 241-249.
22. J.C. Fleege, P.J. van Diest and J.P.A. Baak, Reliability of quantitative pathological assessments, standards, and quality control, in: Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis, J.P.A. Baak, ed., Springer, Berlin, 1991.
23. K.W. Gilchrist, L. Kalish, V.E. Gould, S. Hirschl, J.E. Imbriglia, W.M. Levy, A.S. Patchefsky, D.W. Penner, J. Pickren, J.A. Roth, R.A. Schinella, I.S. Schwarz and J.E. Wheeler, Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study, Breast Cancer Res. Treat. 5 (1985), 3-10 (abstr).
24. D.S. Hopton, J. Thorogood, A.D. Clayden and D. MacKinnon, Observer variation in histological grading of breast cancer, Eur. J. Surg. Oncol. 15 (1989), 21-23.
25. L.P. Howell, R. Gandour-Edwards and D. O'Sullivan, Application of the Scarff-Bloom-Richardson tumour grading system to fine-needle aspirates of the breast, Am. J. Clin. Pathol. 101 (1994), 262-265.
26. H. Kraemer, Extension of the kappa coefficient, Biometrics 36 (1980), 207-216.
27. P. Kronqvist, Y. Collan, T. Kuopio and H. Kujari, Nuclear morphometry in breast cancer: the influence of sampling rules and freezing of samples, Mod. Path. 8 (1995), 187-192.
28. H.P. Kujari, Y.U.I. Collan and N.B. Atkin, Use of the mitotic counts for the prognosis and grading of breast cancer. Method evaluation study, Path. Res. Pract. 190 (1994), 593-599.
29. T.E. Kute, B. Gregory, J. Gallenshaw, M. Hopkins, D. Buss and D. Case, How reproducible are flow cytometry data from paraffin-embedded blocks?, Cytometry 9 (1988), 494-498.
30. T.E. Kute, H.B. Muss, M.R. Cooper, L.D. Case, D. Buss, V. Stanley, B. Gregory, J. Gallenshaw and K. Booher, The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients, Cancer 66 (1990), 1810-1816.
31. J.R. Landis and G.G. Koch, The measurement of observer agreement for categorial data, Biometrics 33 (1977), 159-174.
32. B. Risberg, B. Baldetorp, M. Fernö, B. Hansson, L.L. Mossberg, G. Roos, O. Stål, J.T. Thornthwaite and L. Tibell, Inter-institutional reproducibility of flow cytometric DNA-analysis in breast carcinomas, Anal. Cell. Pathol. 6 (1994), 23-36 (abstr).
33. R. Silvestrini, Quality controls for evaluation of the S-phase fraction by flow cytometry: a multicentric study. The SICCAB Group for Quality Control of Cell Kinetic Determinations, Cytometry 18 (1994), 11-16.
34. F.B. Sörensen, Biology of the disease. Quantitative analysis of nuclear size for objective nuclear grading: a review with emphasis on new, unbiased stereological methods, Lab. Invest. 66 (1992), 4-23.
35. B. Stenkvist, S. Westman-Naeser, J. Vegelius, J. Holmquist, B. Nordlin, E. Bengtson and O. Eriksson, Analysis of reproducibility of subjective grading systems for breast carcinoma, J. Clin. Pathol. 32 (1979), 979-985.
36. F. Theissig, K.D. Kurze, G. Haroske and W. Mayer, Histological grading of breast cancer. Interobserver reproducibility and prognostic significance, Pathol. Res. Pract. 186 (1990), 732-736.
37. F. Theissig, V. Dimmer, G. Haroske, K.D. Kurze and W. Meyer, Use of nuclear image cytometry, histopathologic grading and DNA cytometry to make breast cancer prognosis more objective, Anal. Cell. Pathol. 3 (1991), 351-360 (abstr.).
38. H.R. Wulff, Pålideligheden af Deskriptive Data. Rationel Klinik, Grundlaget for diagnostiske og terapeutiske beslutninger, Copenhagen, 1981, pp. 48-54.